Federated Hermes Inc. Acquires 13,150 Shares of STERIS plc (NYSE:STE)

Federated Hermes Inc. raised its stake in shares of STERIS plc (NYSE:STE - Free Report) by 4.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 328,520 shares of the medical equipment provider's stock after buying an additional 13,150 shares during the period. Federated Hermes Inc. owned approximately 0.33% of STERIS worth $67,531,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Avalon Trust Co bought a new stake in STERIS during the fourth quarter worth approximately $30,000. Human Investing LLC bought a new position in STERIS during the fourth quarter valued at about $31,000. Anfield Capital Management LLC grew its holdings in STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after acquiring an additional 91 shares during the period. Central Pacific Bank Trust Division raised its position in STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after acquiring an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC lifted its holdings in STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after acquiring an additional 137 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the stock. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a report on Monday, April 7th. Piper Sandler boosted their target price on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. JMP Securities reiterated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research report on Thursday. Finally, Stephens restated an "overweight" rating and set a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $258.75.

Remove Ads

STERIS Stock Up 1.9 %

Shares of STE stock traded up $4.06 during trading on Friday, hitting $221.18. 459,313 shares of the company were exchanged, compared to its average volume of 535,699. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The firm has a market capitalization of $21.73 billion, a price-to-earnings ratio of 46.96 and a beta of 0.87. The business's 50-day simple moving average is $222.61 and its 200 day simple moving average is $219.62.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were given a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 1.03%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS's payout ratio is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.